Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy

Shashi Gujar; Jonathan Pol; K. Vishnupriyan; Manuela Lizarralde-Guerrero; Prathyusha Konda; Guido Guido Kroemer; John C. Bell

doi:10.1038/s41596-024-00985-1

Related publications

Article2015

Trial Watch—Oncolytic viruses and cancer therapy

Jonathan Pol, Aitziber Buqué, Fernando Aranda, Norma Bloy, Isabelle Cremer, Alexander Eggermont, Philippe Erbs, Jitka Fučíková, Jérôme Galon, Jean–Marc Limacher, Xavier Préville, Catherine Sautès‐Fridman, Radek Špíšek, Laurence Zitvogel, Guido Guido Kroemer, Lorenzo Galluzzi

Article2015

First oncolytic virus approved for melanoma immunotherapy

Jonathan Pol, Guido Guido Kroemer, Lorenzo Galluzzi

Article2018

Trial Watch: Oncolytic viro-immunotherapy of hematologic and solid tumors

Jonathan Pol, Sarah Lévesque, Samuel T. Workenhe, Shashi Gujar, Fabrice Le Bœuf, Derek R. Clements, Jean‐Eudes Fahrner, Laetitia Fend, John C. Bell, Karen Mossman, Jitka Fučíková, Radek Špíšek, Laurence Zitvogel, Guido Guido Kroemer, Lorenzo Galluzzi

Editorial Material2018

Heating it up: Oncolytic viruses make tumors ‘hot’ and suitable for checkpoint blockade immunotherapies

Shashi Gujar, Jonathan Pol, Guido Guido Kroemer

Article2006

Mathematical modeling of tumor therapy with oncolytic viruses: effects of parametric heterogeneity on cell dynamics

Georgy P. Karev, Artem S. Novozhilov, Eugene V Koonin